Literature DB >> 2362275

Chalcones: a new class of antimitotic agents.

M L Edwards1, D M Stemerick, P S Sunkara.   

Abstract

A series of chalcones was evaluated as antimitotic agents. One of these, (E)-1-(2,5-dimethoxyphenyl)-3-[4-(dimethylamino)phenyl]-2-methyl-2-pr open- 1-one) (73), was found to be an effective antimitotic agent at a concentration of 4 nM in an in vitro HeLa cell test system. When evaluated in experimental tumor models in vivo, this compound exhibited antitumor activity against L1210 leukemia and B16 melanoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2362275     DOI: 10.1021/jm00169a021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

1.  Texas Native Plants Yield Compounds with Cytotoxic Activities against Prostate Cancer Cells.

Authors:  Corena V Shaffer; Shengxin Cai; Jiangnan Peng; Andrew J Robles; Rachel M Hartley; Douglas R Powell; Lin Du; Robert H Cichewicz; Susan L Mooberry
Journal:  J Nat Prod       Date:  2016-01-19       Impact factor: 4.050

2.  Molecular cloning and expression profiling of a chalcone synthase gene from Lamiophlomis rotata.

Authors:  Qiao Feng; Geng Gui-Gong; Zeng Yang; Xie Hui-Chun; Jin Lan; Shang Jun; Chen Zhi
Journal:  J Genet       Date:  2015-06       Impact factor: 1.166

3.  Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues.

Authors:  Casey J Maguire; Graham J Carlson; Jacob W Ford; Tracy E Strecker; Ernest Hamel; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2019-06-04       Impact factor: 3.597

4.  Chalcones bearing a 3,4,5-trimethoxyphenyl motif are capable of selectively inhibiting oncogenic K-Ras signaling.

Authors:  Sarah E Kovar; Cody Fourman; Christine Kinstedt; Brandon Williams; Christopher Morris; Kwang-Jin Cho; Daniel M Ketcha
Journal:  Bioorg Med Chem Lett       Date:  2020-03-28       Impact factor: 2.823

5.  6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.

Authors:  Shengnan Du; Jeffrey G Sarver; Christopher J Trabbic; Paul W Erhardt; Allen Schroering; William A Maltese
Journal:  Cancer Chemother Pharmacol       Date:  2018-11-13       Impact factor: 3.333

Review 6.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

7.  A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent.

Authors:  Yali Kong; Kan Wang; Michael C Edler; Ernest Hamel; Susan L Mooberry; Mikell A Paige; Milton L Brown
Journal:  Bioorg Med Chem       Date:  2009-11-10       Impact factor: 3.641

Review 8.  A Comprehensive Review of Aminochalcones.

Authors:  Rimsha Irfan; Shikufa Mousavi; Meshari Alazmi; Rahman Shah Zaib Saleem
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

9.  Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.

Authors:  Lívia B Salum; Wanessa F Altei; Louise D Chiaradia; Marlon N S Cordeiro; Rafael R Canevarolo; Carolina P S Melo; Evelyn Winter; Bruno Mattei; Hikmat N Daghestani; Maria Cláudia Santos-Silva; Tânia B Creczynski-Pasa; Rosendo A Yunes; José A Yunes; Adriano D Andricopulo; Billy W Day; Ricardo J Nunes; Andreas Vogt
Journal:  Eur J Med Chem       Date:  2013-03-06       Impact factor: 6.514

10.  Type III polyketide synthase repertoire in Zingiberaceae: computational insights into the sequence, structure and evolution.

Authors:  Vijayanathan Mallika; Girija Aiswarya; Paily Thottathil Gincy; Appukuttan Remakanthan; Eppurathu Vasudevan Soniya
Journal:  Dev Genes Evol       Date:  2016-05-02       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.